ACSL4 and Parkinson disease: Given that ACSL4 and GPX4 are pivotal regulators of ferroptosis, lncRNA NEAT1 might modulate ferroptosis via these molecules, presenting a promising therapeutic approach for Parkinson’s disease (Liu et al., 2021; Zhou et al., 2023).